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Abstract
Background & Aims: We have previously shown that the hepatic vagus nerve
stimulates the activation of hepatic progenitor cells (HPC), via muscarinic
acetylcholine receptor type 3. Given the coproliferation of HPC and hepatic
stellate cells (HSC) in acute hepatitis, we determined whether HSC pro-
liferation is also modulated by vagal activity. Methods: We induced acute
hepatitis in Wistar rats by injection of galactosamine and lipopolysacchar-
ides. Hepatitis was preceded by hepatic branch vagotomy or sham vagotomy,
by electrical stimulation or sham stimulation and by muscarinic receptor
antagonist atropine, nicotinic receptor antagonist mecamylamine or saline
injection. Rats were sacrificed after 12 and 48 h and HSC numbers were
quantified on immunohistochemical stainings. Furthermore, we performed
reverse transcriptase-polymerase chain reaction with receptor-specific pri-
mers on total RNA from isolated HSC and determined the in vitro
proliferation of HSC in response to acetylcholine, atropine and mecamyla-
mine. Results: HSC numbers were significantly lower after vagotomy than
after sham vagotomy. Conversely, more HSC were seen after electrical
stimulation than after sham stimulation. Atropine resulted in less HSC than
saline at both time points, while mecamylamine treatment only diminished
HSC after 12 h, suggesting a predominant involvement of muscarinic
receptors. Moreover, HSC express muscarinic receptor type 2 mRNA and
protein, as well as nicotinic receptor a1, a5, b1 and vasoactive intestinal
peptide receptor 1 mRNA. Furthermore, acetylcholine enhanced the in vitro
proliferation of HSC, which was inhibited by atropine, but not by mecamy-
lamine. Conclusions: We show here that the hepatic vagus nerve stimulates
HSC proliferation, most likely through binding of acetylcholine on muscari-
nic receptor type 2.
The liver receives parasympathetic innervation through
the hepatic branch of the vagus nerve, its main efferent
neurotransmitters being acetylcholine (ACh) and vasoac-
tive intestinal peptide (VIP). Besides a role in energy
homeostasis (1) and liver blood flow (2), the vagus nerve
forms the ‘cholinergic anti-inflammatory pathway’ (3)
and is thought to influence liver regeneration (4). It is
known that hepatic branch vagotomy (HV) causes a
delay in regeneration after partial hepatectomy (5).
Stimulation of vagus nerve activity improves this regen-
eration, which is modulated by central neuropeptides
and can be blocked by atropine (4, 6). Furthermore,
hepatic progenitor cells (HPC), immature liver cells that
proliferate to support regeneration when parenchymal
tissue repair is compromised, express muscarinic ACh
receptor type 3 (M3) (7), VIP receptor type 2 (8) and
mRNA for several ACh receptors. We also demonstrated
that HV inhibits proliferation of HPC in galactosamine-
induced acute hepatitis (7), a model where coprolifera-
tion of HPC and hepatic stellate cells (HSC) has been
shown (9).
Hepatic stellate cells are stellate-shaped cells located
perisinusoidally in the space of Disse. In response to liver
injury, HSC transdifferentiate into myofibroblast-like
cells, a change in phenotype characterized by the loss of
vitamin A-containing lipid droplets and the induction of
a-smooth muscle actin expression. These ‘activated’
HSC proliferate, migrate to areas of necrosis and pro-
duce large amounts of extracellular matrix proteins,
growth factors and cytokines to support the regenera-
tion of liver tissue. HSC express several neural and
neuro-endocrine features such as glial fibrillary acidic
protein (GFAP) (10), neural cell adhesion molecule (11),
nestin (12), synaptophysin (13), aB-crystallin (14),
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neurotrophins and neurotrophin-receptors (15). In vitro
incubation of HSC with ACh increased their prolifera-
tion and production of extracellular matrix proteins (16).
In view of these findings, we aimed to determine the
effect of parasympathetic nervous system modulation on
HSC. We evaluated HSC proliferation in acute hepatitis
after modulation of vagal neurotransmission; we per-
formed vagotomies and conversely, electrical stimulation
of the left cervical vagus nerve. We also studied the
receptor expression profile of HSC and blocked nicotinic
ACh receptors using mecamylamine and muscarinic ACh
receptors using atropine. Furthermore, we determined
the effect of ACh, atropine and mecamylamine on HSC
proliferation in vitro.
Materials and methods
Animals and experimental design
Male Wistar rats weighing 250 g were used in the experi-
ments. The rats were fed ad libitum and received
humane care in accordance with the institution’s ethical
guidelines.
Experiment 1
To study the effect of vagotomy on HSC proliferation, 20
rats were subjected to selective HV (7). After anaesthesia
with ketamine and xylazine, a midline laparotomy was
performed and the common hepatic branch was trans-
ected as it separates from the ventral vagal trunk.
A control group consisted of 20 sham-operated animals
(Sham-HV). The rats were allowed to recover for 24 h
before acute hepatitis was established using a single
intravenous injection of galactosamine (GAL, 500
mg/kg; Acros Organics, Geel, Belgium) and lipopolysac-
charides (LPS, 1mg/kg; Sigma, St Louis, MO, USA). Ten
rats of both groups were sacrificed 12 h after intoxication;
the remaining rats were sacrificed after 48 h. After
anaesthesia with pentobarbital (Sanofi, Brussels, Bel-
gium), whole blood was collected by puncture at the
bifurcation site of the abdominal aorta. Liver tissue was
snap-frozen in liquid-nitrogen cooled isopentane and
stored at  80 1C. Serum was assayed for liver function
tests (albumin, aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), alkaline phosphatase and
total and direct bilirubin) by automated procedures.
Glycaemia was measured in whole blood using Glucocard
memory strips (A. Menarini Diagnostics, Zaventem,
Belgium). Serum tumour necrosis factor (TNF)-a levels
were measured by Quantikine enzyme-linked immuno-
sorbent assay according to the manufacturer’s instruc-
tions (R&D systems, Minneapolis, MN, USA).
Experiment 2
Six rats were subjected to electrical stimulation (STIM)
of the left cervical vagus nerve, using a bipolar platinum
electrode (Harvard Apparatus, Holliston, MA, USA).
Voltage stimuli (frequency 5Hz, pulse duration 2ms, at
5 V) were applied 10min before and after GAL1LPS
injection, for 20 continuous min, with the SD9 square
pulse stimulator (Grass Technologies, West Warwick, RI,
USA). For sham stimulation (Sham-STIM, n= 6), the left
cervical vagus nerve was visualized but not stimulated.
All rats were sacrificed after 12 h. The remaining proce-
dures were as described in experiment 1.
Experiment 3
Vagal neurotransmission through nicotinic and muscari-
nic receptors was blocked by administration of mecamy-
lamine and atropine respectively. Immediately before
injection of GAL1LPS, the rats received an intraperito-
neal (i.p.) injection of atropine (1mg/kg in saline, Sterop
NV, Brussels, Belgium) or mecamylamine (1mg/kg in
saline, Sigma). Mecamylamine injections were repeated
every 12 h, atropine was given every 3 h. Control rats
received i.p. injections of saline. All rats (n= 5–10 per
group) were sacrificed after 12 or 48 h. The remaining
procedures were as described in experiment 1.
Hepatic stellate cell isolation
Hepatic stellate cells were isolated from male Wistar rats
weighing 400 g, as described previously (17). In short,
livers were perfused in situ with Hank’s buffered salt
solution and then with Gey’s buffered salt solution
containing collagenase type IV (Sigma) and pronase E
(Merck, Darmstadt, Germany). After excision, the liver
was digested in a shaking suspension of collagenase IV
and pronase E for 30min at 37 1C. HSC were further
enriched by differential centrifugation and subsequent
density centrifugation with Optiprep (Nycomed, Swe-
den). Cells with a density o 1.053 (9% Optiprep) were
harvested (18) and viability was assessed using trypan
blue exclusion. Cells were seeded onto uncoated plastic
culture dishes and cultured in William’s E medium
supplemented with 10% fetal calf serum, 0.6 IU/ml
insulin, 2mM glutamine and 1% antibiotic–antimycotic
solution (Invitrogen, Merelbeke, Belgium). The medium
was renewed three times a week.
Reverse transcriptase-polymerase chain reaction
Hepatic stellate cells were harvested by trypsinization 2
days after the isolation (quiescent HSC) or after the
second passage (culture-activated HSC).
Total RNAwas extracted fromHSC and rat brain using
TRIzol reagent (Invitrogen) and reverse transcribed. The
resulting cDNA was amplified by PCR (1min 94 1C, 30 s
55 1C, 30 s 72 1C, 35 cycles) using primers for muscarinic
and nicotinic ACh and for VIP receptors (supporting
information Table S1). Regions of amplification were
chosen in accordance with published regions of amplifi-
cation (19, 20) or designed with PRIMER3 (Whitehead
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Institute for Biomedical Research). PCR products were
confirmed on 1.5% agarose gel electrophoresis stained
with ethidium bromide. Identification of amplification
products was achieved by sequencing.
Cell proliferation
At subconfluence, cells were removed from the flasks by
light trypsinization and seeded into 96-well plates at
4 104 cells/ml. After 24 h, the medium was replaced
with fresh medium, supplemented with 10% serum and
containing the test drugs; ACh (109–103M), atropine
(105M) and mecamylamine (105M). The cell prolif-
eration assay was performed following manufacturer’s
instructions (Calbiochem, Gibbstown, NJ, USA). Briefly,
the incorporation of bromodeoxyuridine label into newly
synthesized DNA was immunochemically detected and
the colorimetric reaction product was measured at
450 nm, as a measure for active cell proliferation.
Immunohisto- and immunocytochemistry
Immunohistochemistry was performed using rabbit
polyclonal antibodies against GFAP for pericentral HSC
(dilution 1/300, Dako, Glostrup, Denmark), desmin for
periportal HSC (dilution 1/1000, Abcam, Cambridge,
UK) or both antibodies at the same time for identifica-
tion of the total HSC population, on 5mm frozen rat liver
sections (21). After overnight drying and fixation with
acetone for 10min, the sections were incubated for
15min with 5% normal goat serum to prevent back-
ground staining from the secondary antibody. After
incubation with the primary antibodies for 45min, the
secondary step consisted of goat anti-rabbit Envisions
(Dako) for 30min.
Immunocytochemistry was performed on acetone-
fixated HSC, 7 days after isolation. After incubation with
5% normal goat serum, slides were incubated overnight
with a mouse monoclonal antibody against M2 receptor
(dilution 1/50, Abcam). The secondary antibody, goat
anti-mouse Envisions, was pre-adsorbed overnight with
rat liver powder (MP Biomedicals, Illkirch, France) to
reduce non-specific reaction. All dilutions were made in
phosphate buffered saline, pH 7.2. The reaction product
was developed using 3-amino-9-ethylcarbazole (Dako),
and counterstaining was performed with haematoxylin.
Negative controls (omission of the primary antibody)
were consistently negative.
Image analysis
Cell counting of HSC on stained sections was performed
using the image analysis software ANALYSISD (Olympus,
Mu¨nster, Germany). Of each section, eight random
lobular pictures were taken at magnification 100.
Colour thresholds were set to cover the stained area in
order to quantify the HSC. Particles within the right
colour thresholds representing positive HSC with a clear
nucleus were automatically quantified.
Statistics
All data are expressed as mean standard error (SE).
Statistical analysis, with the unpaired Student’s t-test,
was performed using SIGMASTAT 3.5 (Jandel, San Rafael,
CA, USA). Differences were accepted as significant at
Po 0.05.
Results
Hepatitis and evaluation of hepatic stellate cell
proliferation
Injection of GAL1LPS elicited fulminant acute hepatitis,
as indicated by the increase in serum concentrations of
transaminases and histopathological examination of the
liver showing necrosis, infiltration of inflammatory cells
and increased numbers of HPC and HSC. Transaminase
levels showed that the most severe necrosis is reached
12 h after intoxication (Table 1), while the highest
number of HSC on desmin and GFAP stainings is
reached after 48 h (Fig. 1) (22).
Table 1. Possible indirect effects: hepatic branch vagotomy (HV) vs sham vagotomy (Sham-HV)
12 h 48 h
HV Sham-HV HV Sham-HV
Albumin (g/L) 310.4 33 0.9 310.7 330.8
Alkaline phosphatase (U/L) 53748 634 61 65777 56383
AST (U/L) 28831247 2524 1198 25936 19630
ALT (U/L) 1257462 1252 625 12326 6911
Total bilirubin (mg/dl) 0.30.1 0.4 0.2 0.30.1 0.10.01
Direct bilirubin (mg/dl) 0.10.04 0.3 0.14 0.10.09 0.010.00
Glycaemia (mg/dl) 1268 131 7 1226 1387
TNF-a (pg/ml) 7.50.5 8.4 0.8 5.10.2 5.10.2
Rats were sacrificed 12 h and 48 h after intoxication and serum was assayed for parameters shown. Data are expressed as mean SE of 10 rats per
group.
Po 0.05 vs Sham-HV.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; HV, hepatic branch vagotomy; TNF, tumour necrosis factor.
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Loss of function: hepatic branch vagotomy
At 12 h after GAL1LPS injection, HV caused a signifi-
cantly lower number of HSC than Sham-HV (Po 0.001),
as demonstrated by the combined desmin1GFAP staining.
HValso showed less desmin-positive HSC (Po 0.01) than
Sham-HV, while no difference was found in the number of
GFAP-positive HSC (P= 0.49) (Fig. 2A).
At the 48-h time point, total HSC number as well as
desmin-positive and GFAP-positive HSC numbers were
significantly lower for HV than Sham-HV (all Po 0.05,
Figs 1 and 2B), showing that HV inhibits the HSC
proliferation normally seen in acute hepatitis.
Gain of function: electrical stimulation
Using the opposite approach, by stimulating the left
cervical vagus nerve electrically, we found that there were
significantly more HSC in STIM than Sham-STIM, for
the combined (Po 0.05), anti-desmin (Po 0.05) and
anti-GFAP (Po 0.001) staining, at 12 h after GAL1LPS
(Fig. 3), suggesting that STIM promotes the survival and/
or the proliferation of HSC in acute hepatitis.
Vagus nerve stimulates hepatic stellate cell proliferation
through acetylcholine and M2 receptors
Having established that the vagus nerve stimulates HSC
proliferation, we wanted to determine the contribution
of muscarinergic and nicotinergic neurotransmission to
HSC proliferation. Therefore, in the next experiment,
hepatitis was combined with IP injections of mecamyla-
mine (a nicotinic receptor antagonist), atropine (a mus-
carinic receptor antagonist) or saline (as a control).
At the 12-h time point, atropine administration resulted
in a lower number of HSC (Po 0.001) than saline injec-
tion. Moreover, atropine showed less desmin-positive HSC
(Po 0.01), however, no difference was found in GFAP-
positive HSC (P= 0.22, Fig. 4A). Mecamylamine also
reduced the HSC number as indicated by all three stainings
Fig. 1. Hepatic branch vagotomy inhibits proliferation of hepatic stellate cells in acute hepatitis. Representative liver histology sections of
hepatic vagotomy (HV, left panel) and sham vagotomy (Sham-HV, right panel), 48 h after induction of acute hepatitis. Hepatic stellate cells
were stained for desmin1GFAP (A), desmin (B) or GFAP (C). Original magnification  100, insets 500.
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(all Po 0.001, Fig. 4A). This indicates that both receptor
types are important for the onset of HSC proliferation in
the early phase of hepatitis. At 48 h after GAL1LPS
injection, atropine-treated livers showed a lower total
HSC number (Po 0.05) than control livers, resulting from
less desmin- (Po 0.05) and GFAP-positive (Po 0.01)
HSC (Fig. 4B). Mecamylamine, however, failed to show
differences in HSC number at 48 h, for total (P= 0.66),
desmin-positive (P= 0.9) and GFAP-positive (P= 0.12)
HSC compared with control (Fig. 4B), suggesting a
predominant involvement of muscarinic ACh receptors in
vagal stimulation of later HSC proliferation.
Hepatic stellate cells express M2 receptor and mRNA for
other vagal neurotransmitter receptors
Reverse transcriptase-polymerase chain reaction (RT-PCR)
for neurotransmitter receptors revealed that quiescent HSC
express mRNA for muscarinic ACh receptor subtype 2
(Fig. 5A), nicotinic ACh receptor subtype a1, a5 and b1
(Fig. 5B) and for VIP receptor type 1 (Fig. 5C). Moreover,
culture-activated HSC express M2, M3, M4 and M5
receptor mRNA (Fig. 5A) and M2 receptor protein (Fig.
5D). This indicates that HSC exhibit the necessary tools to
respond to direct nerve stimulation.
Possible indirect effects of vagus nerve modulation on
hepatic stellate cell
Modulation of vagus nerve activity can influence many
hepatic and systemic processes, all of which could explain
the observed differences in HSC proliferation. To ascer-
tain that the differences in HSC proliferation resulted
from direct nerve influence, we performed liver function
tests on serum and measured glycaemia and serum
TNF-a levels. Although we did find a slightly lower serum
albumin level in HV than Sham-HV at the 12-h time
point, no differences were found in alkaline phosphatase,
transaminase and bilirubin levels, at 12 or 48 h (Table 1).
At the 12-h time point, mecamylamine treatment resulted
in higher AST levels (Po 0.05) than control but, given
the systemic administration of mecamylamine and simi-
lar ALT levels as control (P= 0.2), this probably does not
reflect a higher degree of liver necrosis (Table 2). Atropine
caused higher total and direct bilirubin levels than con-
trol at 12 h (both Po 0.05, Table 2), which can be
explained by decreased bile duct motility. Atropine
administration resulted in a higher TNF-a at 12 h and
strikingly, a lower TNF-a at 48 h, compared with control
saline-treated animals (Table 2). Blood glucose levels did
not differ from the appropriate controls in any of the
treatment groups. None of the parameters was different
in STIM compared to Sham-STIM (data not shown).
Fig. 2. Hepatic branch vagotomy inhibits proliferation of hepatic
stellate cells (HSC) in acute hepatitis. HSC of hepatic branch
vagotomized (HV) and Sham-vagotomized (Sham-HV) rats were
stained for desmin1GFAP, desmin, and GFAP and quantified using
image analysis, 12 h (A) and 48 h (B) after induction of acute
hepatitis. HSC are expressed as average number per section SE.
n= 10 per group. Po0.05, #Po 0.01, wPo 0.001.
Fig. 3. Electrical stimulation promotes survival and/or proliferation
of hepatic stellate cells (HSC) in acute hepatitis. HSC were stained for
desmin1GFAP, desmin and GFAP and quantified using image
analysis, 12 h after induction of acute hepatitis, in rats of which the
left cervical vagus nerve was electrically stimulated (STIM, n= 6) or
sham-stimulated (Sham-STIM, n= 6). HSC are expressed as average
number per section SE. Po 0.05, #Po0.001.
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Acetylcholine stimulates hepatic stellate cell proliferation
in vitro
To establish whether vagal neurotransmitters can directly
influence HSC proliferation, we added ACh to HSC in
culture. A pilot experiment (with ACh concentrations
ranging from 109 to 103M) revealed that ACh exerted
its maximal stimulatory effect on HSC proliferation at
107M (Po 0.001) and 106M (Po 0.05, Fig. 6A).
Addition of atropine completely inhibited the stimula-
tion by ACh (Po 0.05), whereas mecamylamine did not
(Fig. 6B). This suggests that the M2 receptor on HSC
mediates the in vitro effect of ACh, while nicotinic
receptors do not seem to be involved.
Discussion
We show here, for the first time, that inhibition of
hepatic vagus nerve activity by HV or by blockage of
muscarinic ACh receptors with atropine results in in-
hibition of the HSC proliferation that normally occurs in
acute hepatitis. Conversely, more HSC were present after
electrical stimulation of the left cervical vagus nerve,
which is upstream of the hepatic branch. Furthermore,
we show that HSC express mRNA for several vagal
neurotransmitter receptors and M2 receptor protein and
thus the necessary machinery to respond to vagal stimu-
lation directly. These present results are an extension of
our previous study, in which we showed that HV
diminished the proliferation of HPC (7); cells expressing
M3 receptors and known to coproliferate with HSC in
GAL-induced acute hepatitis (9). Taken together, our
results indicate that the vagus nerve, through ACh and
muscarinic receptors, plays an important role in the
activation of the regenerative compartment, consisting
of HPC and HSC, upon toxic liver injury.
The results of this study are in agreement with
previous investigations that examined the influence of
vagus nerve activity on liver regeneration in other
models. After partial hepatectomy, HV was reported to
delay the increase in hepatic DNA synthesis and thymi-
dine kinase activity, thereby delaying hepatic regenera-
tion (23). Stimulation of autonomic nuclei in the
hypothalamus produced an increase in cell proliferation
in the liver and facilitated hepatic regeneration after
partial hepatectomy (24). Moreover, these effects were
reached through vagal, cholinergic and muscarinic me-
chanisms (6). Furthermore, hepatocytes were shown to
express M3 receptor mRNA (25). Experiments in which
bile duct-ligated rats underwent cervical vagotomy re-
vealed that the vagus nerve directly stimulates growth of
cholangiocytes via binding of acetylcholine to the M3
receptor (26). Moreover, isolated bile duct units and
isolated cholangiocytes were reported to express M3
receptor (27). We therefore suggest the existence of a
functional syncytium in the liver, controlled through
vagal muscarinic pathways that can act upon liver injury
to regenerate and repopulate the liver.
It is generally accepted that there is little or no
intralobular innervation in rat liver, while for instance
guinea pig liver parenchyma is densely innervated.
Furthermore, the extent of intralobular innervation seems
to be inversely correlated to the number of signal-
propagating gap junctions, because in guinea pig liver a
low, but in rat liver a high density of gap junctions has
been demonstrated (28, 29). So in the proposed func-
tional syncytium, nerve signal propagation from the
portal zone to cells in more pericentral regions depends
largely on this type of communication. In this regard,
Nelles et al. (30) demonstrated that in connexin32-
deficient mice – with hepatocytes lacking functional gap
junctions – the sympathetic nerve stimulation-dependent
increase in glucose output was severely impaired.
Fig. 4. Blocking of muscarinic receptors has a larger inhibitory
effect on proliferation of hepatic stellate cells (HSC) in acute hepatitis
than blocking of nicotinic receptors. Muscarinic and nicotinic
receptors were blocked by atropine (ATR) and mecamylamine
(MEC), respectively. HSC were stained for desmin1GFAP, desmin
and GFAP and quantified using image analysis, 12 h (A) and 48 h (B)
after induction of acute hepatitis. HSC are expressed as average
number per section SE. n= 5–10 per group. Po0.05, #Po0.01,
wPo0.001.
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The situation in HSC can be analogous to that in
hepatocytes, namely periportal – innervated – HSC can
respond directly to vagal neurotransmitters and pass
the nervous signal, via cell–cell communication, on to
pericentral HSC – that probably lack direct innervation.
Moreover, it has been shown that expression of inter-
mediate filament desmin is most abundant in HSC in the
portal area and that its expression decreases towards the
Fig. 5. Hepatic stellate cells (HSC) express M2 receptor and several other receptors for vagal neurotransmitters. Reverse transcriptase-
polymerase chain reaction for muscarinic (A) and nicotinic (B) acetylcholine receptor subtypes and for VIP (C) receptors. L, ladder; qS, quiescent
HSC; aS, activated HSC; B, brain; P, hepatic progenitor cells. (D) Immunostaining for M2 receptor on cultured HSC. Original magnification
50, details 200.
Table 2. Possible indirect effects: atropine and mecamylamine vs control
12 h 48 h
ATR MEC Control ATR MEC Control
Albumin (g/L) 390.9 38 1.4 37 0.8 35 1.2 370.8 360.9
Alkaline phosphatase (U/L) 81024 911 55 770 54 761 97 95077 759102
AST (U/L) 109252614 15680 2547 8530 2166 404 139 534223 29986
ALT (U/L) 61831024 8877 1462 5834 1559 231 105 560217 18450
Total bilirubin (mg/dl) 1.80.3 1.5 0.3 0.9 0.2 0.8 0.3 0.60.1 0.60.2
Direct bilirubin (mg/dl) 1.20.2 1.0 0.3 0.6 0.1 0.5 0.2 0.30.1 0.20.1
Glycaemia (mg/dl) 67.810.8 62.1 12.1 92.9 9.2 81.8 3.7 77.35.8 75.12.6
TNF-a (pg/ml) 15.11.2 11.1 0.7 10.1 0.9 5.5 0.2 6.90.5 6.70.3
Rats were sacrificed 12 h and 48 h after intoxication and serum was assayed for parameters shown. Data are expressed as mean SE. n= 5–10 per
group.
Po 0.05 vs control.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ATR, atropine; MEC, mecamylamine.
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centrolobular veins. While the opposite holds true for
GFAP expression in HSC, there is a significant amount of
double-positive HSC located in zone 2 of the lobules (21,
31). This indicates that desmin-positive HSC are more
likely to be innervated than GFAP-positive HSC. Because
the positivity of HSC for desmin or GFAP as well as their
innervation status is associated with their location in the
lobule, this explains the discrepancies we found in HV
and ATR at the 12-h time point: the lack of difference in
GFAP-positive HSC while total and desmin-positive HSC
numbers did differ from their respective controls.
To rule out possible effects on HSC caused indirectly
by vagally influenced processes, we carefully checked
parameters of liver disease, glucose homeostasis and
inflammation. After HV or STIM, no differences were
found in any of the liver parameters, except for a slightly
lower albumin value at 12 h in HV than in Sham-HV,
indicating a similar degree of hepatocellular damage
in both experimental groups. We did not observe
differences in glucose levels after any of the nerve
modulations we performed. This is in line with the
findings of Xue et al. (32) who reported no difference in
basal glucose output after HV. Other authors did report a
higher basal glucose output after HV (33) but because
they conducted insulin-clamp experiments in the setting
of liver perfusion, their results are not necessarily compar-
able to our in vivo results. In contrast to numerous papers
showing the anti-inflammatory capacity of the vagal
nerve (34), we did not observe differences in TNF-a levels
after HV or STIM. One possible explanation for this
discrepancy might be the bi-directional communication
that exists between HSC and inflammatory cells. HSC do
not only respond to cytokines from inflammatory cells
but also produce cytokines themselves to attract inflam-
matory cells to the injured region (35). Therefore, a lower
HSC proliferation after HV may balance the aggravating
effect of HV on inflammation. At present, we cannot
explain the TNF-a levels found after atropine, but one
should keep in mind that it was administered systemi-
cally, and that its effects are not limited to the liver.
To further strengthen our hypothesis of a direct effect
of vagal activity on HSC, we confirmed our in vivo
findings by performing proliferation experiments with
ACh on HSC in vitro. We demonstrated that ACh
enhances the proliferation of HSC, an effect that is
inhibited by atropine. Despite an important in vivo effect
at the 12-h time point, mecamylamine did not inhibit the
in vitro ACh-induced proliferation nor the in vivo pro-
liferation after 48 h. Bearing in mind that HSC undergo
activation in culture, this might suggest that nicotinic
ACh receptors stimulate the onset of HSC proliferation
but lose this ability further on in the activation process.
Our results are a further indication of a vagal muscarinic
effect on HSC proliferation and corroborate the ACh-
induced enhanced HSC proliferation shown by Oben
et al. (16). Furthermore, muscarinic receptors have been
shown to mediate the ACh-induced proliferation of rat
astrocytes and human astrocytoma cells (36) and to
regulate the migration and wound epithelialization of
keratinocytes (37). Because HSC express M2 receptor
that is coupled via a Gi type protein, the stimulatory
effect of ACh on HSC proliferation is probably mediated
through inhibition of cAMP production by adenylate
cyclase (Fig. 7). With low levels of this second messenger,
protein kinase A remains inactive, which in its turn leaves
transcription factors such as CREB unphosphorylated,
allowing HSC to proliferate (38). High levels of cAMP
were shown to maintain HSC in their quiescent state and
inhibit their proliferation (39, 40).
In conclusion, we show here that the hepatic vagus
nerve stimulates HSC proliferation in acute hepatitis,
through binding of ACh on the M2 receptor expressed on
HSC. HSC proliferation is necessary for adequate repair
of liver tissue. However, perpetuated proliferation (and
activation) of HSC is considered to be a key event in the
development of fibrosis. Further studies are now war-
ranted to unravel the effects of modulation of vagus
Fig. 6. Acetylcholine (ACh) enhances the proliferation of hepatic
stellate cells (HSC) in vitro, an effect that is abolished by atropine.
(A) Addition of ACh to medium containing 10% serum stimulates
the proliferation of HSC. (B) This ACh-induced stimulation of
HSC proliferation is inhibited by atropine (ATR), but not by
mecamylamine (MEC). All values are expressed as mean
absorbance SE of HSC from six different isolations and are
depicted as percentage of the response in serum-free conditions.
Po0.05 vs 10% serum, wPo0.001 vs 10% serum, #Po 0.05
vs ACh.
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nerve activity on fibrogenic capacity of HSC. It is
conceivable that targeted interruption of vagal innerva-
tion may provide an interesting viewpoint in the quest
for antifibrogenic therapies.
Acknowledgements
The authors thank Nicoletta Sinelli for her assistance
with the RT-PCR.
Financial support: D. Cassiman received financial
support from the Fund for Scientific Research (FWO
Vlaanderen).
References
1. Puschel GP. Control of hepatocyte metabolism by sympa-
thetic and parasympathetic hepatic nerves. Anat Rec A
Discov Mol Cell Evol Biol 2004; 280: 854–67.
2. Gardemann A, Puschel GP, Jungermann K. Nervous con-
trol of liver metabolism and hemodynamics. Eur J Biochem
1992; 207: 399–411.
3. Tracey KJ. The inflammatory reflex. Nature 2002; 420:
853–9.
4. Kiba T. The role of the autonomic nervous system in
liver regeneration and apoptosis – recent developments.
Digestion 2002; 66: 79–88.
5. Ohtake M, Sakaguchi T, Yoshida K, Muto T. Hepatic
branch vagotomy can suppress liver regeneration in par-
tially hepatectomized rats. HPB Surg 1993; 6: 277–86.
6. Yoneda M, Kono T, Watanobe H, et al. Central thyrotropin-
releasing hormone increases hepatic cyclic AMP through
vagal-cholinergic and prostaglandin-dependent pathways
in rats. Peptides 2005; 26: 1573–9.
7. Cassiman D, Libbrecht L, Sinelli N, et al. The vagal nerve
stimulates activation of the hepatic progenitor cell
compartment via muscarinic acetylcholine receptor type
3. Am J Pathol 2002; 161: 521–30.
8. Cassiman D, Sinelli N, Bockx I, et al. Human hepatic
progenitor cells express vasoactive intestinal peptide recep-
tor type 2 and receive nerve endings. Liver Int 2007; 27:
323–8.
9. Dabeva MD, Shafritz DA. Activation, proliferation, and
differentiation of progenitor cells into hepatocytes in the
D-galactosamine model of liver regeneration. Am J Pathol
1993; 143: 1606–20.
10. Gard AL, White FP, Dutton GR. Extra-neural glial fibrill-
ary acidic protein (GFAP) immunoreactivity in perisinu-
soidal stellate cells of rat liver. J Neuroimmunol 1985; 8:
359–75.
11. Nakatani K, Seki S, Kawada N, Kobayashi K, Kaneda K.
Expression of neural cell adhesion molecule (N-CAM) in
perisinusoidal stellate cells of the human liver. Cell Tissue
Res 1996; 283: 159–65.
12. Niki T, Pekny M, Hellemans K, et al. Class VI intermediate
filament protein nestin is induced during activation of rat
hepatic stellate cells. Hepatology 1999; 29: 520–7.
13. Cassiman D, van Pelt J, De Vos R, et al. Synaptophysin:
a novel marker for human and rat hepatic stellate cells.
Am J Pathol 1999; 155: 1831–9.
14. Cassiman D, Roskams T, van Pelt J, et al. Alpha B-crystallin
expression in human and rat hepatic stellate cells. J Hepatol
2001; 35: 200–7.
15. Cassiman D, Denef C, Desmet VJ, Roskams T. Human and
rat hepatic stellate cells express neurotrophins and neuro-
trophin receptors. Hepatology 2001; 33: 148–58.
16. Oben JA, Yang S, Lin H, Ono M, Diehl AM. Acetylcholine
promotes the proliferation and collagen gene expression of
myofibroblastic hepatic stellate cells. Biochem Biophys Res
Commun 2003; 300: 172–7.
17. Laleman W, Van Landeghem L, Severi T, et al. Both Ca21
-dependent and -independent pathways are involved in rat
hepatic stellate cell contraction and intrahepatic hyperre-
sponsiveness to methoxamine. Am J Physiol Gastrointest
Liver Physiol 2007; 292: G556–64.
18. Alpini G, Phillips JO, Vroman B, LaRusso NF. Recent
advances in the isolation of liver cells. Hepatology 1994; 20:
494–514.
19. Krejci A, Tucek S. Quantitation of mRNAs for M(1) to
M(5) subtypes of muscarinic receptors in rat heart and
brain cortex. Mol Pharmacol 2002; 61: 1267–72.
20. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S.
Functional expression and tissue distribution of a novel
receptor for vasoactive intestinal polypeptide.Neuron 1992;
8: 811–9.
21. Niki T, De Bleser PJ, Xu G, et al. Comparison of glial
fibrillary acidic protein and desmin staining in normal and
CCl4-induced fibrotic rat livers. Hepatology 1996; 23:
1538–45.
22. Jonker AM, Dijkhuis FW, Kroese FG, Hardonk MJ, Grond
J. Immunopathology of acute galactosamine hepatitis in
rats. Hepatology 1990; 11: 622–7.
Fig. 7. M2 receptor pathway. Acetylcholine binds to the M2
receptor, which is coupled to a Gi type protein. The a-subunit
becomes activated, dissociates from the bg-subunit and inhibits
adenylate cyclase. As a consequence, cAMP levels remain low,
which renders protein kinase A inactive.
Liver International (2010)
c 2010 John Wiley & Sons A/S 701
Bockx et al. Vagus nerve and stellate cell proliferation
23. Tanaka K, Ohkawa S, Nishino T, Niijima A, Inoue S. Role of
the hepatic branch of the vagus nerve in liver regeneration
in rats. Am J Physiol 1987; 253: G439–444.
24. Kiba T, Tanaka K, Numata K, Hoshino M, Inoue S.
Facilitation of liver regeneration after partial hepatectomy
by ventromedial hypothalamic lesions in rats. Pflugers Arch
1994; 428: 26–9.
25. Vatamaniuk MZ, Horyn OV, Vatamaniuk OK, Doliba NM.
Acetylcholine affects rat liver metabolism via type 3 mus-
carinic receptors in hepatocytes. Life Sci 2003; 72: 1871–82.
26. LeSage G, Alvaro D, Benedetti A, et al. Cholinergic system
modulates growth, apoptosis, and secretion of cholangio-
cytes from bile duct-ligated rats. Gastroenterology 1999;
117: 191–9.
27. Alvaro D, Alpini G, Jezequel AM, et al. Role and mechan-
isms of action of acetylcholine in the regulation of rat
cholangiocyte secretory functions. J Clin Invest 1997; 100:
1349–62.
28. Reilly FD, McCuskey PA, McCuskey RS. Intrahepatic dis-
tribution of nerves in the rat. Anat Rec 1978; 191: 55–67.
29. Forssmann WG, Ito S. Hepatocyte innervation in primates.
J Cell Biol 1977; 74: 299–313.
30. Nelles E, Butzler C, Jung D, et al. Defective propagation of
signals generated by sympathetic nerve stimulation in the
liver of connexin32-deficient mice. Proc Natl Acad Sci USA
1996; 93: 9565–70.
31. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T.
Hepatic stellate cell/myofibroblast subpopulations in fibro-
tic human and rat livers. J Hepatol 2002; 36: 200–9.
32. Xue C, Aspelund G, Sritharan KC, et al. Isolated hepatic
cholinergic denervation impairs glucose and glycogen
metabolism. J Surg Res 2000; 90: 19–25.
33. Matsuhisa M, Yamasaki Y, Shiba Y, et al. Important role of
the hepatic vagus nerve in glucose uptake and production
by the liver. Metabolism 2000; 49: 11–6.
34. Tracey KJ. Physiology and immunology of the cholinergic
antiinflammatory pathway. J Clin Invest 2007; 117: 289–96.
35. Maher JJ. Interactions between hepatic stellate cells and the
immune system. Semin Liver Dis 2001; 21: 417–26.
36. Guizzetti M, Costa P, Peters J, Costa LG. Acetylcholine as a
mitogen: muscarinic receptor-mediated proliferation of rat
astrocytes and human astrocytoma cells. Eur J Pharmacol
1996; 297: 265–73.
37. Chernyavsky AI, Arredondo J, Wess J, Karlsson E, Grando
SA. Novel signaling pathways mediating reciprocal control
of keratinocyte migration and wound epithelialization
through M3 and M4 muscarinic receptors. J Cell Biol
2004; 166: 261–72.
38. Pinzani M, Marra F, Carloni V. Signal transduction in
hepatic stellate cells. Liver 1998; 18: 2–13.
39. Bennett RG, Mahan KJ, Gentry-NielsenMJ, Tuma DJ. Relaxin
receptor expression in hepatic stellate cells and in cirrhotic rat
liver tissue. Ann N YAcad Sci 2005; 1041: 185–9.
40. Chen YX, Zhang XR, Xie WF, Li S. Effects of taurine on
proliferation and apoptosis of hepatic stellate cells in vitro.
Hepatobiliary Pancreat Dis Int 2004; 3: 106–9.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Primer sequences: Sequences of forward
(F) and reverse (R) primers in 50–30 direction, used in
RT-PCR reactions for neurotransmitter receptors.
Please note: Wiley-Blackwell is not responsible for
the content or functionality of any supporting materials
supplied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
Liver International (2010)
702 c 2010 John Wiley & Sons A/S
Vagus nerve and stellate cell proliferation Bockx et al.
